TRELEGY ELLIPTA
Google image searchProduct monograph
Active ingredients
fluticasone furoate, 100 MCG/ACT
umeclidinium (umeclidinium bromide), 62.5 MCG/ACT
vilanterol (vilanterol trifenatate), 25 MCG/ACT
DIN: 02474522
Dosage form(s): POWDER
Route(s) of administration: INHALATION
Schedule: Prescription
Company: GLAXOSMITHKLINE INC
Date: 30-MAY-2018
ATC:
- R03 — DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD, )
- R03A — ADRENERGICS, INHALANTS (ATC, ATC/DDD)
- R03AL — Adrenergics in combination with anticholinergics (ATC, ATC/DDD)
- R03AL08 — VILANTEROL, UMECLIDINIUM BROMIDE AND FLUTICASONE FUROATE (ATC/DDD)
External Links for Trelegy Ellipta
Search on Google
- Trelegy Ellipta side effects
- Trelegy Ellipta dosage
- fluticasone furoate side effects
- fluticasone furoate dosage
- umeclidinium side effects
- umeclidinium dosage
- vilanterol side effects
- vilanterol dosage
Glaxosmithkline Inc
Go to GlaxoSmithKline website to see drug product details. Sometimes you can find trelegy ellipta photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.